At Elanco (NYSE: ELAN) – it all starts with animals!

As a global leader in animal health, we are dedicated to innovation and delivering products and services to prevent and treat disease in farm animals and pets. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People.

At Elanco, we pride ourselves on fostering a diverse and inclusive work environment. We believe that diversity is the driving force behind innovation, creativity, and overall business success. Here, you’ll be part of a company that values and champions new ways of thinking, work with dynamic individuals, and acquire new skills and experiences that will propel your career to new heights.

Making animals’ lives better makes life better – join our team today!

Your Role:

The purpose of the sales representative role in Elanco is to create demand and secure sales by professionally promoting, differentiating, delivering and demonstrating the value of Elanco products and services to customers and the people who influence their product use decisions. Sales representatives are held accountable for delivering sales results, managing territory business plan, aligning Elanco activities with account needs, and creating strategic territory/account plans and implement implementing agreed upon initiatives within those plans.

Your Responsibilities:

Develop and execute a territory plan including prioritization of opportunities which will deliver sustainable sales growth within the territory
Deliver and transfer Key Messages and scientific information around Elanco products to key influencers / decision makers within the designated sales territory
Identify and assess customer needs
Uncover customer’s solvable problems and opportunities
Utilize Elanco’s CRM system for both capturing relevant information and gleaning insight as part of the pre-call planning process
Incorporate the Elanco product portfolio (products and services) as a part of the solution
Work closely with salespeople and other internal teams to meet individual and group objectives
Execute strategies and tactics with corporate accounts to enhance account team’s ability to execute effectively under constantly changing circumstances
Achieve sales growth in territory
Represent the “voice of the customer” to Elanco management and marketing

What You Need to Succeed (Minimum Qualifications):

Education: Bachelor Degree in related field or relevant experience.
Required Experience: 2 years Sales or poultry production experience
Experience selling insecticides
Valid driver’s license and acceptable driving record
Qualified candidates must be legally authorized to be employed in the United States. Elanco does not anticipate providing sponsorship for employment visa status (e.g., H-1B or TN status) for this employment position.

What Will Give You the Competitive Edge (Preferred Qualifications):

Passion for selling and animal agriculture
Ability to work with and influence custom insecticide applicators.
Ability to work with and influence swine, broiler, turkey and layer integrators along with key distributors.
Demonstrated ability to develop goals, key milestones and action plans for key accounts
Savvy ability to develop, advance and maintain strong relationships
Self-starter with high initiative and sound work ethic
Demonstrated ability to learn, apply and communicate technical/scientific knowledge
Flexible to learning new products and disease states over time
Strong team member with ability to interact and coordinate a diverse set of resources across the customer base
Entrepreneur mind set with strong grasp of business acumen
Ability to relocate if necessary

Additional Information:

Position is field based.
Travel will be required. Overnight travel will depend on location; expect 40-60% overnight travel.
Majority of customers are located in Southeast United States (Alabama, Georgia, Mississippi area)

Don’t meet every single requirement? Studies have shown underrecognized groups are less likely to apply to jobs unless they meet every single qualification. At Elanco we are dedicated to building a diverse and inclusive work environment. If you think you might be a good fit for a role but don't necessarily meet every requirement, we encourage you to apply. You may be the right candidate for this role or other roles!

Elanco Benefits and Perks:

We offer a comprehensive benefits package focusing on financial, physical, and mental well-being while encouraging our employees to pursue our purpose! Some highlights include:

Multiple relocation packages
Two weeklong shutdowns (mid-summer and year-end) in the US (in addition to PTO)
8-week parental leave
9 Employee Resource Groups
Annual bonus offering
Flexible work arrangements
Up to 6% 401K matching

Elanco currently anticipates that the base salary for this position could range from $85,500 to $143,100 depending partly on the successful candidate’s qualifications, including education and experience. Full-time equivalent employees also will be eligible for a company bonus (depending partly on company and individual performance). Additionally, Elanco offers a comprehensive benefit program to eligible employees that includes a company-matching 401(k); vacation benefits; eligibility for medical, dental, vision, and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities). Of course, the compensation is subject to change and could be higher or lower than the range described above. Elanco reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion, and Elanco’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Elanco employees.

Elanco is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status

Elanco may use automated tools, including AI, to support parts of our recruitment process, such as reviewing applications against job‑related criteria and/or transferrable skills. These tools help ensure a consistent, structured evaluation, but they do not make hiring decisions. All decisions involve a human reviewer. For more information on how we handle personal data, please see our Elanco Workforce Privacy Notice.

About the company

Elanco is a global animal health company that develops medicines, vaccines, and preventive care products for livestock and pets. Its products include prescription medicines, vaccines, and parasite-control solutions used by veterinarians, farmers, and pet owners to protect animal health and welfare and improve productivity. After separating from Eli Lilly in 2019, Elanco expanded its scale by acquiring Bayer Animal Health in 2020, which broadened its reach in the companion-animal market and added direct-to-consumer capabilities. Its goal is to advance animal health and welfare worldwide by providing effective, accessible products and services while growing sustainably as a standalone company.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Indianapolis, Indiana

Founded

1954

Get referred to Elanco

See people who can refer or advise you

Simplify's Take

What believers are saying

August 5, 2026 Q2 revenue reached $1.368 billion, with 8% organic constant-currency growth.
August 26, 2026 Elwood expansion quadrupled mAb capacity, supporting Befrena and Trutect.
Elanco raised 2026 innovation revenue to $1.25 billion and targets unconstrained Befrena supply by early 2027.

What critics are saying

December 2025 restructuring hit 600 roles and $175 million charges, with closures continuing through 2026.
Seventh Circuit affirmed Elanco's securities case on August 14, 2026, keeping disclosure risk alive.
Befrena demand is twice expectations; any manufacturing or safety setback would cripple Elanco's biologics thesis.

What makes Elanco unique

Elanco owns one of two animal-health monoclonal antibody platforms, centered in Elwood, Kansas.
Befrena and Trutect give Elanco proprietary biologics manufacturing control, not outsourced dependence.
Elanco spans farm and pet health, unlike narrower companion-animal rivals like Zoetis.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours
Hybrid Work Options
401(k) Company Match
Parental Leave
Annual Bonus
Relocation Assistance

Growth & Insights and Company News

6 month growth

1 year growth

2 year growth

PR Newswire

Oct 22nd, 2026

Elanco names Eli Lilly's Jamie Preston chief people officer as Dave Kinard retires

Elanco Animal Health has appointed Jamie Preston as executive vice president and chief people officer, effective November 3. She succeeds Dave Kinard, who plans to retire at the end of the year and will help with the transition. Preston joins from Eli Lilly and Company, where she spent 23 years. Most recently she was vice president of HR, global compensation and workforce innovation, leading compensation for an organisation of more than 50,000 employees. "Jamie is a visionary, dynamic leader with the speed and agility that defines Elanco," said chief executive officer Jeff Simmons. Simmons said employee engagement is the highest since Elanco's IPO, crediting Kinard's leadership. Kinard also oversaw the move of the company's headquarters from Greenfield to Indianapolis.

WBIW

Oct 15th, 2026

Purdue, Elanco break ground on new One Health Research Institute in Indianapolis.

Purdue, Elanco break ground on new One Health Research Institute in Indianapolis. October 15, 2026 INDIANAPOLIS - Purdue University and Elanco Animal Health have broken ground on a new research facility designed to advance health solutions for people, animals, plants and the environment. University, industry and government leaders gathered Tuesday, Oct. 6, to mark the beginning of construction on the One Health Research Institute, part of the developing One Health Innovation District near downtown Indianapolis. The planned 150,000-square-foot facility will feature advanced research laboratories, shared equipment and research infrastructure, business incubator space, collaboration areas and facilities supporting animal health and veterinary partners. Purdue will serve as the institute's academic and research anchor, connecting faculty, students and researchers with industry partners and entrepreneurs. Elanco will contribute its animal health expertise and scientific resources while helping connect research discoveries with the development and commercialization of new solutions. The institute is intended to encourage collaboration across scientific disciplines, recognizing that human, animal, plant and environmental health are interconnected. Purdue Interim President Mitch Daniels said the project supports the university's land-grant mission while expanding its presence in Indianapolis and contributing to Indiana's economic growth. The institute is expected to create opportunities for research partnerships and innovation that could help address complex health challenges.

Feed and Additive

Oct 14th, 2026

NOVUS appoints two sales managers in Indonesia.

NOVUS appoints two sales managers in Indonesia. 14 October 2026 NOVUS has appointed veterinarians Hendri Ahadianto and Lucia Simanjuntak as sales managers in Indonesia. Based in Jakarta, they will work with customers across the country on animal health, nutrition and feed-related challenges. NOVUS has expanded its commercial team in Indonesia with the appointment of veterinarians Hendri Ahadianto and Lucia Simanjuntak as sales managers. Based in Jakarta, Ahadianto and Simanjuntak work with customers throughout Indonesia, bringing experience in animal health, nutrition, feed additives, customer relationship management and technical evaluation. According to NOVUS, their expertise strengthens the company's ability to collaborate with feed mills, integrators, nutritionists and producers as poultry, swine and dairy customers navigate changing feed costs, raw-material variability and other production challenges. Simanjuntak's expertise includes poultry nutrition and health, feed additive formulation, intestinal health risk management, and evaluating the technical and economic benefits of nutrition programs. She works with customers to connect feed mill considerations with farm performance through formulation assessment, field trials, performance data and return-on-investment analysis. "What I enjoy most is solving practical customer problems and seeing the results in the field," says Lucia Simanjuntak. "Indonesia's animal agriculture industry faces changing feed ingredients, production pressures and animal health challenges, so continuous learning and strong customer relationships are essential. I look forward to combining technical knowledge with NOVUS resources to help customers develop practical feeding programs that deliver measurable value." Ahadianto brings nearly 20 years of animal health industry experience, with a background in communication, leadership and relationship building. In his role, he combines those skills with business analysis to understand customers' challenges and identify practical options for their operations. "After many years in animal health, joining NOVUS gives me an opportunity to take on a new challenge and expand my experience in animal nutrition," Hendri Ahadianto says. "Building close relationships is important to me. I want to understand each customer's business and work alongside them to find practical solutions to the challenges they face." Rika Riantika, Senior Regional Sales Manager at NOVUS, says the different backgrounds of her two newest colleagues strengthen the support NOVUS can provide customers in Indonesia. "Lucia and Hendri bring valuable but complementary experience to our team," says Riantika. "Hendri's extensive animal health background, business perspective and ability to build strong customer relationships pair well with Lucia's experience in animal health, nutrition solutions and technical evaluation. Together, they strengthen our ability to understand what customers are facing and connect them with the expertise and resources available through NOVUS." Before joining NOVUS, Lucia Simanjuntak served as sales manager for western Indonesia with Huvepharma Animal Health Indonesia. She also served as business manager for western Indonesia with Evonik Indonesia. Simanjuntak earned her doctorate in veterinary medicine from Gadjah Mada University in Yogyakarta, Indonesia. Hendri Ahadianto previously served as a strategic account manager with Elanco Animal Health. He also held sales and technical roles with Zoetis, Pfizer Animal Health, and Romindo Primavetcom. He earned his veterinary degree from Airlangga University in Surabaya, Indonesia.

RB Magazine

Oct 1st, 2026

Beef specialist joins Elanco's southern team.

Beef specialist joins Elanco's southern team. Leading animal health company, Elanco, has announced the appointment of Claire Scott as its new territory manager for southern NSW and Riverina. Claire brings almost a decade's experience in beef production via previous roles with a leading Angus stud in southern NSW and an integrated grazing, lot feeding and cropping operation in WA. "With practical experience and technical knowledge in beef production, nutrition, genetics and data-based performance systems, Claire is a great asset for our southern farm animal team," Elanco farm animal business unit head, Jamie Dowsley, says "She also has a keen interest in animal health and welfare, having spent four years as a veterinary nurse at two veterinary practices in Perth, WA. "Claire has proven herself to be extremely confident working with livestock producers and their advisors to develop practical programs that improve animal health, productivity and operations." Claire holds a Bachelor of Science (Veterinary Nursing) from Letterkenny Institute of Technology, Ireland, as well as Level IV certificates in Agriculture and Work Health & Safety. More recently, she has completed the Marcus Oldham Rural Leadership Program and Rabobank Farm Managers P rogram. Reporting to Regional Sales Manager - South, Mark McLennan, Claire joins other five other Territory Managers in Elanco's southern team: Alice Lewis (Southern NSW), Jas Marshall (Central Victoria), Colin Andrews (SE South Australia & West Vic), Brent Burgess (Tasmania/Gippsland) and Wayne Clonan (Northern SA, Broken Hill & Sunraysia).

Feedstuffs

Sep 18th, 2026

Bimeda USA expands anti-parasitic line for cattle.

Bimeda USA expands anti-parasitic line for cattle. Moxisolv Pour-On is an FDA-approved bioequivalent option containing 0.5% moxidectin. September 18, 2026 Bimeda is expanding its anti-parasitic portfolio with MoxiSolv Pour-On (moxidectin), initially available in 5 L and 10 L sizes for cattle producers. Bimeda is pleased to announce the expansion of its anti-parasitic portfolio with the addition of MoxiSolv(TM) Pour-On (moxidectin). MoxiSolv Pour-On is the first available Food & Drug Administration-approved, bioequivalent alternative to Cydectin(R) Pour-On (moxidectin) by Elanco and is initially available in 5 L and 10 L sizes for producers. MoxiSolv Pour-On is a ready-to-use topical parasiticide containing 0.5% moxidectin and is labeled for use in beef and dairy cattle of all ages, including lactating dairy cows. It provides treatment and control of gastrointestinal roundworms, lungworms, cattle grubs, mites, lice and horn flies. Moxidectin pour-on products offer a zero-day milk withdrawal and a short pre-slaughter withdrawal time, giving producers flexibility compared to pour-on products that carry longer withdrawal periods. MoxiSolv Pour-On features a purple dye for visible application and is formulated for consistent pour and absorption across the hide. It is manufactured in the U.S. under strict quality standards and offers producers a trusted bioequivalent option in a familiar pour-on format. A unique benefit of moxidectin is that it is dung-beetle friendly. Healthy dung beetle populations have been shown to play a key role in maintaining soil health in pastures, and they also aid producers' efforts in controlling internal and external parasites. As dung beetles disperse manure, they reduce breeding environments for horn flies and limit further exposure to gastrointestinal nematodes. Dr. Eric Moore, DVM, head of technical services North America at Bimeda, said, "Producers continue to look for parasite control solutions that balance efficacy, safety and environmental stewardship. MoxiSolv Pour-On delivers reliable moxidectin performance in a convenient pour-on format while supporting dung beetle populations that contribute to healthier pastures. It's a product that aligns with both animal health and long-term sustainability goals." Feedstuffs is the news source for animal agriculture

Elanco

Insecticides Senior Sales Representative

About the job